{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View {2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	BLNK Gene (Entity type)	-0.0040570227
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	TFF3 Gene (Entity type)	-0.004416067
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	S100A9 Gene (Entity type)	0.005684331
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	S100A8 Gene (Entity type)	0.0083278045
Alectinib Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	0.3719746768474579
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CXCL8 Gene (Entity type)	-0.004095279
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	lorazepam Compound (Entity type)	0.4505556523799896
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	NT5E Gene (Entity type)	-0.004174218
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	F3 Gene (Entity type)	-0.0045470423
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CD59 Gene (Entity type)	0.0042771264

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
BLNK
Gene (Entity type)
-0.0040570227

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
TFF3
Gene (Entity type)
-0.004416067

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
S100A9
Gene (Entity type)
0.005684331

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
S100A8
Gene (Entity type)
0.0083278045

Alectinib
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
0.3719746768474579

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CXCL8
Gene (Entity type)
-0.004095279

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
lorazepam
Compound (Entity type)
0.4505556523799896

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
NT5E
Gene (Entity type)
-0.004174218

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
F3
Gene (Entity type)
-0.0045470423

{2-methyl-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CD59
Gene (Entity type)
0.0042771264

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.